{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:15:18Z","timestamp":1761884118016,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.reumae.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T12:19:16Z","timestamp":1628252356000},"page":"368-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-RNA polymerase III antibodies in systemic sclerosis: Multicentric study from Argentina"],"prefix":"10.1016","volume":"18","author":[{"given":"Mar\u00eda de los \u00c1ngeles","family":"Gargiulo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Sarano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Bazzalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela","family":"Pend\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Josefina","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2021.02.003_bib0005","series-title":"Reumatolog\u00eda","first-page":"336","article-title":"Esclerosis sist\u00e9mica (esclerodermia)","author":"Medsger","year":"2010"},{"key":"10.1016\/j.reumae.2021.02.003_bib0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies","volume":"49","author":"Reveille","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2021.02.003_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reumae.2021.02.003_bib0020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2008.06.010","article-title":"Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies","volume":"7","author":"Koenig","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reumae.2021.02.003_bib0025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","article-title":"Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies","volume":"67","author":"Hamaguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2021.02.003_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/ar4241","article-title":"What autoantibody tests should become widely available to help scleroderma diagnosis and management?","volume":"15","author":"Muro","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2021.02.003_bib0035","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.coi.2007.11.004","article-title":"Pathogenic autoantibodies in systemic sclerosis","volume":"19","author":"Gabrielli","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.reumae.2021.02.003_bib0040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3899\/jrheum.090600","article-title":"Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors","volume":"37","author":"Ingraham","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2021.02.003_bib0045","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2021.02.003_bib0050","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/art.27549","article-title":"Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies","volume":"62","author":"Shah","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2021.02.003_bib0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3899\/jrheum.160817","article-title":"Malignancies in patients with anti-RNA polymerase III antibodies and systemic sclerosis: analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening","volume":"44","author":"Lazzaroni","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2021.02.003_bib0060","first-page":"104","article-title":"Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis","volume":"34","author":"Meyer","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2021.02.003_bib0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/08916934.2011.592886","article-title":"Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients","volume":"44","author":"Rodriguez-Reyna","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.reumae.2021.02.003_bib0070","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van der Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.02.003_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000104742.42401.e2","article-title":"The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with Systemic Lupus Erythematosus: ethnic and disease heterogeneity among \"Hispanics\u201d","volume":"83","author":"Pons-Estel","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 29","key":"10.1016\/j.reumae.2021.02.003_bib0080","first-page":"60","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2021.02.003_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.reumae.2021.02.003_bib0090","series-title":"Esclerodermia","first-page":"251","article-title":"Compromiso articular, tendinoso y miopat\u00eda en esclerodermia","author":"Gut","year":"2015"},{"key":"10.1016\/j.reumae.2021.02.003_bib0095","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1002\/art.21232","article-title":"Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis","volume":"52","author":"Kuwana","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2021.02.003_bib0100","first-page":"1528","article-title":"Antibodies to RNA polymerase III in systemic sclerosis as detected by an ELISA","volume":"34","author":"Santiago","year":"2007","journal-title":"J Rheumatol"},{"year":"2019","series-title":"Anti-RNA polimerasa III data sheet","key":"10.1016\/j.reumae.2021.02.003_bib0105"},{"key":"10.1016\/j.reumae.2021.02.003_bib0110","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/BOR.0b013e3282e7d8f9","article-title":"Update on autoantibodies in systemic sclerosis","volume":"19","author":"Walker","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.reumae.2021.02.003_bib0115","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/rheumatology\/ken201","article-title":"Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA","volume":"47","author":"Parker","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.reumae.2021.02.003_bib0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/37.1.15","article-title":"Anti-RNA polymerases and other autoantibodies specificities in systemic sclerosis","volume":"37","author":"Bunn","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.reumae.2021.02.003_bib0125","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.ejim.2017.07.033","article-title":"Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?","volume":"44","author":"Benyamine","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.reumae.2021.02.003_bib0130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","article-title":"For the GENISOS StudyGroup. Systemic sclerosis in 3US ethnic groups: a comparison of clinical, sociodemographic, serologic and immunogenetic determinants","volume":"30","author":"Reveille","year":"2001","journal-title":"Semin Arthritis Reum"},{"key":"10.1016\/j.reumae.2021.02.003_bib0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/art.38219","article-title":"Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: new data from a French cohort and a systematic review and meta-analysis","volume":"66","author":"Sobanski","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2021.02.003_bib0140","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.autrev.2009.02.002","article-title":"Anti-RNA polymerase III: a marker of systemic sclerosis with rapid onset and skin thickening progression","volume":"8","author":"Cavazzana","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reumae.2021.02.003_bib0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2008.03739.x","article-title":"Watermelon stomach in systemic sclerosis: its incidence and management","volume":"28","author":"Marie","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.reumae.2021.02.003_bib0150","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.semarthrit.2016.05.008","article-title":"Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: a Scleroderma Clinical Trials Consortium study","volume":"46","author":"Valenzuela","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reumae.2021.02.003_bib0155","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/art.34319","article-title":"The origin of tendon friction rubs in patients with systemic sclerosis: a sonographic explanation","volume":"64","author":"Cuomo","year":"2012","journal-title":"Arthritis Rheum"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574321001520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574321001520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:02:43Z","timestamp":1761879763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574321001520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2173574321001520"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2021.02.003","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-RNA polymerase III antibodies in systemic sclerosis: Multicentric study from Argentina","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2021.02.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}